pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 14·1 min read
save

Anthropic launches Claude Science AI platform for biotech labs in Kendall Square

Jul 14, 2026·read at STAT ↗Neutral

Anthropic has introduced Claude Science, an application that tailors its large language model for use in biopharma research laboratories. The tool is being positioned for the Kendall Square biotech hub in Cambridge, Massachusetts.

The launch comes amid widespread debate about artificial intelligence, with many fearing job losses and broader societal risks. Anthropic frames the product as a way to enhance scientific work rather than replace staff.

If adopted widely, Claude Science could give researchers faster access to data analysis, literature review and experimental design, potentially accelerating drug discovery efforts in the Boston area.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Anthropic’s Claude Science is coming for Kendall Square”

read at STAT ↗
396 words · retrieved Jul 14
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

drugs
Immunology
topics
Alzheimer's DiseaseEndocrinology & MetabolismImmunology

related stories

  • 20h agoArsenalBio lays off 99 employees, leaving ‘core team’ to advance in vivo strategyBioSpace
  • Aug 6Chutes & Ladders—BioNTech brings in Sobi CEOFierce Biotech
  • Jul 15STAT+: A new biotech startup tries to tackle obesity, but not in the way you might expectSTAT
  • Jul 14STAT+: Akero team, backed by Fairmount, launches new immunology companySTAT
  • 3d agoEli Lilly inks $2.88B Merida buyout for autoimmune drugs against rogue antibodiesFierce Biotech